Regardless of the precise mechanism responsible for DDO inhibition, the potential relevance of DDO as a pharmacological target in schizophrenia shown by this and previous finding18 prompts to the discovery of novel compounds with inhibitory activity for this enzyme, as recently reported by Homma and co-workers48. This evidence concerns the gene DDO and schizophrenia.